New Search

If you are not happy with the results below please do another search

1383 search results for:

1354

Towards earlier detection of ovarian cancer?

According to Cancer Research UK, the incidence of ovarian cancer in the UK is around 7500 new cases per year, accounting for 4% of all new cancer cases in females. The overall 5-year survival rate is around 46%, dropping to 35% at the 10-year mark, a relatively poor prognosis, but almost double that of 40 […]

1355

Urinary KAPPA and LAMBDA (B&F), CE-IVD marked, turbidimetric assays

TRIMERO offers urinary KAPPA and LAMBDA (bound and free) Light Chains CE marked turbidimetric immunoassays (TIA). Applications are available for the most popular clinical chemistry analysers, for both urine and serum samples. The assays, based on polyclonal specific antibodies, have been developed specifically to test “neat” urine samples, and results, with excellent repeatability, correlate well […]

1359

Chronic inflammatory bowel diseases

Laboratory tests play an important role in the diagnosis and differentiation of chronic inflammatory bowel diseases, enabling endoscopies to be avoided in many cases. By Dr Jacqueline Gosink Fecal calprotectin (FC) has in recent years become an established marker for distinguishing chronic inflammatory bowel diseases (CIBD) from functional gut disorders such as irritable bowel syndrome […]